Summary
Cigna Group's Q2 2024 report indicates a strong increase in total revenues, driven primarily by a significant rise in pharmacy revenues, reflecting growth from new clients and organic expansion within its Evernorth Health Services segment. While total shareholders' net income saw a decrease year-over-year, largely due to a substantial impairment of equity securities in Q1 2024, the adjusted income from operations showed a healthy increase, demonstrating resilience in underlying business performance. The company's Cigna Healthcare segment experienced moderate revenue growth and improved profitability, supported by higher premium rates and expense management, though a slight decline in medical customers was noted. Liquidity remains robust with significant cash reserves and undrawn credit facilities. The company continues to execute on its capital deployment strategy, including substantial share repurchases and the upcoming sale of its Medicare Advantage businesses, which is expected to yield approximately $3.7 billion. Overall, Cigna appears to be navigating a dynamic healthcare landscape effectively, with core business segments showing operational strength despite market headwinds and one-time financial impacts.
Financial Highlights
47 data points| Revenue | $60.52B |
| Cost of Revenue | $44.49B |
| Gross Profit | $16.03B |
| SG&A Expenses | $3.68B |
| Operating Income | $2.41B |
| Interest Expense | $378.00M |
| Net Income | $1.55B |
| EPS (Basic) | $5.51 |
| EPS (Diluted) | $5.45 |
| Shares Outstanding (Diluted) | 284.05M |
Key Highlights
- 1Total revenues increased by 25% year-over-year to $60.5 billion, driven by a 33% surge in pharmacy revenues to $45.1 billion, primarily due to new clients and organic growth in Evernorth Health Services.
- 2Shareholders' net income decreased by 53% to $1.27 billion for the six months ended June 30, 2024, primarily impacted by a $1.8 billion impairment of equity securities in Q1 2024.
- 3Adjusted income from operations increased by 10% to $3.78 billion for the six months ended June 30, 2024, driven by strong performance in both Evernorth Health Services and Cigna Healthcare segments.
- 4The Cigna Healthcare segment reported a 4% increase in adjusted revenues and a notable 11% increase in pre-tax adjusted income from operations, benefiting from higher premium rates and improved expense ratios.
- 5Medical customers decreased by 2% to 19.04 million, primarily attributed to a decline in Individual and Family Plans customers within the Cigna Healthcare segment.
- 6The company entered into an agreement to sell its Medicare Advantage businesses to Health Care Service Corporation (HCSC) for approximately $3.7 billion, expected to close in Q1 2025, with proceeds primarily allocated to share repurchases.
- 7Liquidity is strong, with $7.0 billion in cash and short-term investments and $6.5 billion in undrawn committed capacity under revolving credit agreements.